Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ADX10061 fails smoking cessation trial

Addex (SWX:ADXN) discontinued development of ADX10061 for smoking cessation after the

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE